Skip to content

LDA client 202541

NEPHRON PHARMACEUTICALS CORPORATION

Open official API record

Source-supplied identity

Client details

Exact LDA ID: 202541
State: SC
Country: US
Source client ID: 75

Developer and manufacturer of sterile inhalation and 503B outsourcing medication.

Exact source ID relationship

Recent filings

7 total

NEPHRON PHARMACEUTICALS CORPORATIONTHE VOGEL GROUP · 2nd Quarter (Apr 1 - June 30) 2026
Jul 20, 2026
NEPHRON PHARMACEUTICALS CORPORATIONTHE VOGEL GROUP · 1st Quarter (Jan 1 - Mar 31) 2026
Apr 20, 2026
NEPHRON PHARMACEUTICALS CORPORATIONTHE VOGEL GROUP · 4th Quarter (Oct 1 - Dec 31) 2025
Jan 19, 2026
NEPHRON PHARMACEUTICALS CORPORATIONTHE VOGEL GROUP · 3rd Quarter (July 1 - Sep 30) 2025
Oct 20, 2025
NEPHRON PHARMACEUTICALS CORPORATIONTHE VOGEL GROUP · 2nd Quarter (Apr 1 - June 30) 2025
Jul 21, 2025
NEPHRON PHARMACEUTICALS CORPORATIONTHE VOGEL GROUP · 1st Quarter (Jan 1 - Mar 31) 2025
Apr 20, 2025
NEPHRON PHARMACEUTICALS CORPORATIONTHE VOGEL GROUP · 2nd Quarter (Apr 1 - June 30) 2025
Apr 7, 2025

Identity boundary

This page groups filings only by the exact numeric identifier supplied by the LDA API. Politically.com does not merge similar names or infer organizational relationships.